This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Human SALL1 and SALL2P1 transription factors are abundantly expressed in human neural stem cells and in specific phenotypes within the mature human brain. However, these transcription factors are minimally expressed (SALL1) or not detectable (SALL2P1) in neuroblastoma cell lines. To determine the influence of these transcription factors on neural stem cell proliferation, and neural stem cell maturation into terminally differentiatted neurons, astrocytes and oligodendrocytes, experiments will be performed to establish in neural stem cells either continued SALL expression, or a state of SALL down-modulation. To permanently maintain SALL expression, normal human neural stem cells will be transfected with lentiviral-based expression vectors incorporating the gene for the SALL isoform (heterologous transgene expression). The reciprocal analysis, i.e., induction of 'loss-of-function' of a specific SALL isoform, will be mediated by RNA-mediated interference (RNAi). The knock-down of SALL isoform expression will be established either transiently, permanently, or via an inducible mechanism. The regulation of SALL isoform expression will allow us to examine whether these transcription factors influence: a) maintenance of a proliferative state in undifferentiated normal human neural stem cells; b) the profile of neural stem cells differentiating into neurons, astrocytes oroligodendrocytes; and c) maintenance of a differentiated phenotype in neurons, astrocytes and oligodendrocytes.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR018757-04
Application #
7382042
Study Section
Special Emphasis Panel (ZRR1-RI-3 (01))
Project Start
2006-05-01
Project End
2007-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
4
Fiscal Year
2006
Total Cost
$52,772
Indirect Cost
Name
Roger Williams Hospital
Department
Type
DUNS #
625899281
City
Providence
State
RI
Country
United States
Zip Code
02908
Kim, Joseph W; Vang, Souriya; Luo, John Zq et al. (2017) Effects of bone marrow on the microenvironment of the human pancreatic islet: A Protein Profile Approach. Mol Cell Endocrinol 450:32-42
Luo, John Z Q; Kim, Joseph W; Luo, LuGuang (2016) EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET ? CELL IN VITRO. Eur J Pharm Med Res 3:110-119
Tang, Jin Bo; Wu, Ya Fang; Cao, Yi et al. (2016) Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons. Sci Rep 6:20643
Kim, Joseph W; Luo, John Z; Luo, Luguang (2015) The Biochemical Cascades of the Human Pancreatic ?-Cells: The Role of MicroRNAs. J Bioanal Biomed 7:
Luo, Lu Guang; Xiong, Fang; Ravassard, Philippe et al. (2015) Human Bone Marrow Subpopulations Sustain Human Islet Function and Viability In vitro. Br J Med Med Res 8:576-587
Ilgun, Handenur; Kim, Joseph William; Luo, LuGuang (2015) Adult Stem Cells and Diabetes Therapy. J Stem Cell Res Transplant 2:
Bartos, Adrian; Dubielecka, Patrycja M (2014) The emerging role of Bcr-Abl-induced cystoskeletal remodeling in systemic persistence of leukemic stem cells. Curr Drug Deliv 11:582-91
Chorzalska, A; Dubielecka, P M (2014) New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance. Leuk Suppl 3:S7-8
Chorzalska, A; Salloum, I; Shafqat, H et al. (2014) Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia 28:2165-77
Dabiri, Ganary; Heiner, Douglas; Falanga, Vincent (2013) The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds. Expert Opin Emerg Drugs 18:405-19

Showing the most recent 10 out of 90 publications